STOK - Stoke Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-05-09)
Last
 9.36		 Change
 ⇑ +0.31   (+3.43%)		 Volume
  1,197,293
Open
 9.07		 High
 9.60		 Low
 9.05
8EMA (Daily)
 9.26		 40EMA (Daily)
 8.57		 50EMA (Daily)
 8.63		 STO (Daily)
 72.765		 MACD Hist (Daily)
 0.039
8EMA (Weekly)
 8.726		 40EMA (Weekly)
 10.09		 50EMA (Weekly)
 10.24		 STO (Weekly)
 44.115		 MACD Hist (Weekly)
 0.397
Company Profile
Stoke Therapeutics Inc is engaged in developing antisense oligonucleotide medicines. The medicine increases gene expression to treat genetic epilepsies and other severe monogenic diseases, including genetic conditions affecting the central nervous system, eye, liver, and kidney.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com